Search Results - "Food and Drug Administration"

Avaliação da legislação e normas vigentes para bioensaios aplicados em pesquisa clínica: um estudo de caso para comprovação de imunogenicidade de vacinas by Ester Ribeiro de Figueiredo, Sheila Maria Barbosa de Lima, Priscila da Nobrega Rito, Erika Martins de Carvalho

Connect to this object online.

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data by Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina

Connect to this object online.

OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies by Pantelis Natsiavas, Pantelis Natsiavas, Richard D. Boyce, Marie-Christine Jaulent, Marie-Christine Jaulent, Marie-Christine Jaulent, Vassilis Koutkias, Vassilis Koutkias

Connect to this object online.

A questionnaire-based study to assess the status and perspective of fixed-dose combination among the various stakeholders including regulators, clinicians, researchers, and industr... by Krishan Kumar Bhardwaj, K Bangarurajan, Tanveer Naved, Satyendra Kumar Rajput

Connect to this object online.

Drug prescribing during pregnancy in a central region of Italy, 2008-2012 by Martina Ventura, Alice Maraschini, Paola D'Aloja, Ursula Kirchmayer, Ilaria Lega, Marina Davoli, Serena Donati

Connect to this object online.

Comparative analysis of PD‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL‐2 stimulation data by Daren Austin, Murad Melhem, Yash Gandhi, Sharon Lu, Sandra Visser

Connect to this object online.

Access to medicines during the coronavirus (COVID-19) epidemic by Patrycja Kurowska, Wojciech Giermaziak

Connect to this object online.

Adverse events in patients with advanced urothelial carcinoma treated with erdafitinib: a retrospective pharmacovigilance study by Tengfei Yuan, Faping Li, Yuchuan Hou, Hui Guo

Connect to this object online.

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Carbapenem-Resistant <i>Escheri... by Kamonchanok Jitaree, Korbtham Sathirakul, Jantana Houngsaitong, Orarik Asuphon, Weerayuth Saelim, Visanu Thamlikitkul, Preecha Montakantikul

Connect to this object online.

The Role of Co-Enzyme Q10 in The Respiratory Chain and Some of Its Clinical Indications: A review by Noor Al-H, Zeina Al-Thanoon

Connect to this object online.

Techniques for navigating postsurgical adhesions: Insights into mechanisms and future directions by Jiahui Chen, Xiaoqi Tang, Ziyu Wang, Arielle Perez, Benjamin Yao, Ke Huang, Yang Zhang, Martin W. King

Connect to this object online.

An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism by Yuan Gao, Wei Shi, Wei Shi, Hongyu Yao, Yongqiang Ai, Yongqiang Ai, Ruisheng Li, Zhilei Wang, Zhilei Wang, Tingting Liu, Tingting Liu, Wenzhang Dai, Wenzhang Dai, Xiaohe Xiao, Xiaohe Xiao, Jun Zhao, Ming Niu, Zhaofang Bai, Zhaofang Bai

Connect to this object online.

Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain by Howard S Smith, Timothy R Deer

Connect to this object online.

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis by Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis

Connect to this object online.

Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib by El-Osta H, Shackelford R

Connect to this object online.

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database by Dan Zhao, Wangxin Zhang, Yan Liu, Zhaojun Yan

Connect to this object online.

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System by Yamin Shu, Yufeng Ding, Yanxin Liu, Pan Wu, Xucheng He, Qilin Zhang

Connect to this object online.

A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein by Hui Li, Juan Liu, Xiaojuan Xiao, Shuming Sun, Hui Zhang, Yibin Zhang, Weihua Zhou, Bin Zhang, Mridul Roy, Hong Liu, Mao Ye, Zi Wang, Feng Liu-Smith, Jing Liu

Connect to this object online.

Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021) by Ashima Dhiman, Rupam Sharma, Rajesh K. Singh

Connect to this object online.

Alzheimer's and Parkinson's disease therapies in the clinic by Puja Chopade, Neha Chopade, Zongmin Zhao, Samir Mitragotri, Rick Liao, Vineeth Chandran Suja

Connect to this object online.